Cytek Biosciences, Inc.Cytek Biosciences, Inc.Cytek Biosciences, Inc.

Cytek Biosciences, Inc.

No trades
See on Supercharts

CTKB fundamentals

Cytek Biosciences, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of CTKB for the last quarter is 51.50 M USD, and it's 10.47% higher compared to the previous quarter. The net income of Q3 24 is 941.00 k USD.

Q1 '20
Q2 '20
Q3 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: USD
Q1 '20
Q2 '20
Q3 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth